NovoCure NVCR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$71.14M-190% | -$24.5M+34.3% | -$37.27M+7.1% | -$40.14M-17.0% | -$34.32M+47.9% | ||
| $4.12M-2.2% | $4.22M+15.2% | $3.66M+6.4% | $3.44M+3.6% | $3.33M+7.1% | ||
| $63.01M+218% | $19.82M-32.4% | $29.32M+12.2% | $26.14M-11.5% | $29.55M-52.9% | ||
| -$13.52M+24.9% | -$18M-188% | $20.57M+229% | -$15.94M+55.3% | -$35.67M-933% | ||
| $5.15M+5.2% | $4.9M-13.4% | $5.66M+3.1% | $5.49M-48.3% | $10.61M+18.7% | ||
| $7.75M-97.7% | $336.33M+371% | $71.44M+98.5% | $35.99M+656% | -$6.47M+70.9% | ||
| $0— | $0-100% | $99.98M— | $0— | $0— | ||
| $0-100% | $560.95M— | $0— | $0— | $0— | ||
| -$166K+100.0% | -$559.49M-657% | $100.52M+4,111% | $2.39M-54.5% | $5.25M+95.4% | ||
| -$6.07M+97.5% | -$241.25M-225% | $192.51M+748% | $22.7M+162% | -$36.66M-58.7% | ||
| -$18.67M+18.5% | -$22.9M-253% | $14.92M+170% | -$21.42M+53.7% | -$46.28M-273% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NovoCure generate?
- NovoCure (NVCR) generated -$26.9M in operating cash flow over the trailing twelve months.
- What is NovoCure's free cash flow?
- After $21.2M of capital expenditures, NovoCure's free cash flow was -$48.1M over the trailing twelve months, up 33.4% year over year.
- Where does NovoCure's cash flow data come from?
- Every line is extracted from NovoCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
